ID   RNF14_HUMAN             Reviewed;         474 AA.
AC   Q9UBS8; A0AV26; A6NMR2; A8MTW5; B3KN72; B7ZLV2; D3DQE4; O94793;
AC   Q6IBV0;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   10-MAY-2017, entry version 164.
DE   RecName: Full=E3 ubiquitin-protein ligase RNF14;
DE            EC=2.3.2.- {ECO:0000250|UniProtKB:O60260};
DE   AltName: Full=Androgen receptor-associated protein 54;
DE   AltName: Full=HFB30;
DE   AltName: Full=RING finger protein 14;
DE   AltName: Full=Triad2 protein;
GN   Name=RNF14; Synonyms=ARA54; ORFNames=HRIHFB2038;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fetal brain;
RX   PubMed=10320776; DOI=10.1016/S0167-4781(99)00045-7;
RA   Ueki N., Seki N., Yano K., Masuho Y., Saito T., Muramatsu M.-A.;
RT   "Isolation and characterization of a novel human gene (HFB30) which
RT   encodes a protein with a RING finger motif.";
RL   Biochim. Biophys. Acta 1445:232-236(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND CHARACTERIZATION.
RC   TISSUE=Prostate;
RX   PubMed=10085091; DOI=10.1074/jbc.274.13.8570;
RA   Kang H.-Y., Yeh S., Fujimoto N., Chang C.;
RT   "Cloning and characterization of human prostate coactivator ARA54, a
RT   novel protein that associates with the androgen receptor.";
RL   J. Biol. Chem. 274:8570-8576(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Thyroid;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 286-474 (ISOFORM 1), AND
RP   SUBCELLULAR LOCATION.
RC   TISSUE=Fetal brain;
RX   PubMed=9853615; DOI=10.1038/4315;
RA   Ueki N., Oda T., Kondo M., Yano K., Noguchi T., Muramatsu M.-A.;
RT   "Selection system for genes encoding nuclear-targeted proteins.";
RL   Nat. Biotechnol. 16:1338-1342(1998).
RN   [9]
RP   MUTAGENESIS OF CYS-220.
RX   PubMed=11322894; DOI=10.1046/j.1432-1327.2001.02169.x;
RA   Ito K., Adachi S., Iwakami R., Yasuda H., Muto Y., Seki N., Okano Y.;
RT   "N-terminally extended human ubiquitin-conjugating enzymes (E2s)
RT   mediate the ubiquitination of RING-finger proteins, ARA54 and RNF8.";
RL   Eur. J. Biochem. 268:2725-2732(2001).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-348, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   FUNCTION, AND INTERACTION WITH AR.
RX   PubMed=19345326; DOI=10.1016/j.ccr.2009.02.021;
RA   Xu K., Shimelis H., Linn D.E., Jiang R., Yang X., Sun F., Guo Z.,
RA   Chen H., Li W., Chen H., Kong X., Melamed J., Fang S., Xiao Z.,
RA   Veenstra T.D., Qiu Y.;
RT   "Regulation of androgen receptor transcriptional activity and
RT   specificity by RNF6-induced ubiquitination.";
RL   Cancer Cell 15:270-282(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-348, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Might act as an E3 ubiquitin-protein ligase which
CC       accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes
CC       and then transfers it to substrates, which could be nuclear
CC       proteins. Could play a role as a coactivator for androgen- and, to
CC       a lesser extent, progesterone-dependent transcription.
CC       {ECO:0000269|PubMed:19345326}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine. {ECO:0000250|UniProtKB:O60260}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts with the ubiquitin-conjugating enzymes UBE2E1
CC       and UBE2E2. Interacts with AR/androgen receptor; testosterone- and
CC       RNF6-regulated it promotes AR transcriptional activity.
CC       {ECO:0000269|PubMed:19345326}.
CC   -!- INTERACTION:
CC       P10275:AR; NbExp=2; IntAct=EBI-2130308, EBI-608057;
CC       Q9UI36-2:DACH1; NbExp=5; IntAct=EBI-2130308, EBI-10186082;
CC       P51668:UBE2D1; NbExp=4; IntAct=EBI-2130308, EBI-743540;
CC       Q9Y2X8:UBE2D4; NbExp=4; IntAct=EBI-2130308, EBI-745527;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:9853615}.
CC       Nucleus {ECO:0000269|PubMed:9853615}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UBS8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UBS8-2; Sequence=VSP_045780;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC   -!- DOMAIN: The N-terminal destruction box (D-box) acts as a
CC       recognition signal for degradation via the ubiquitin-proteasome
CC       pathway. {ECO:0000250}.
CC   -!- DOMAIN: The RING-type zinc finger is essential for the interaction
CC       with UBE2E2.
CC   -!- DOMAIN: Members of the RBR family are atypical E3 ligases. They
CC       interact with the E2 conjugating enzyme UBE2L3 and function like
CC       HECT-type E3 enzymes: they bind E2s via the first RING domain, but
CC       require an obligate trans-thiolation step during the ubiquitin
CC       transfer, requiring a conserved cysteine residue in the second
CC       RING domain. {ECO:0000250|UniProtKB:O60260}.
CC   -!- PTM: RING-type zinc finger-dependent and UBE2E2-dependent
CC       autoubiquitination.
CC   -!- SIMILARITY: Belongs to the RBR family. RNF14 subfamily.
CC       {ECO:0000305}.
CC   -!- CAUTION: Lacks the His residue in the RING-type domain 2 that is
CC       one of the conserved features of the family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB022663; BAA78677.1; -; mRNA.
DR   EMBL; AF060544; AAD21842.1; -; mRNA.
DR   EMBL; AK023884; BAG51234.1; -; mRNA.
DR   EMBL; AK057868; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; CR456702; CAG32983.1; -; mRNA.
DR   EMBL; AC005740; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471062; EAW61895.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61896.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61897.1; -; Genomic_DNA.
DR   EMBL; BC126185; AAI26186.1; -; mRNA.
DR   EMBL; BC144061; AAI44062.1; -; mRNA.
DR   EMBL; AB015333; BAA34792.1; -; mRNA.
DR   CCDS; CCDS4270.1; -. [Q9UBS8-1]
DR   CCDS; CCDS4271.1; -. [Q9UBS8-2]
DR   RefSeq; NP_001188294.1; NM_001201365.1. [Q9UBS8-1]
DR   RefSeq; NP_004281.1; NM_004290.4. [Q9UBS8-1]
DR   RefSeq; NP_899645.1; NM_183398.2. [Q9UBS8-2]
DR   RefSeq; NP_899646.1; NM_183399.2. [Q9UBS8-1]
DR   RefSeq; NP_899647.1; NM_183400.2. [Q9UBS8-1]
DR   RefSeq; NP_899648.1; NM_183401.2. [Q9UBS8-1]
DR   RefSeq; XP_005268593.1; XM_005268536.2. [Q9UBS8-1]
DR   RefSeq; XP_005268594.1; XM_005268537.2. [Q9UBS8-1]
DR   RefSeq; XP_005268596.1; XM_005268539.2. [Q9UBS8-2]
DR   RefSeq; XP_005268597.1; XM_005268540.3. [Q9UBS8-2]
DR   RefSeq; XP_005268598.1; XM_005268541.3. [Q9UBS8-2]
DR   RefSeq; XP_011536016.1; XM_011537714.2. [Q9UBS8-1]
DR   RefSeq; XP_016865559.1; XM_017010070.1. [Q9UBS8-1]
DR   RefSeq; XP_016865560.1; XM_017010071.1. [Q9UBS8-2]
DR   RefSeq; XP_016865561.1; XM_017010072.1. [Q9UBS8-2]
DR   UniGene; Hs.483616; -.
DR   ProteinModelPortal; Q9UBS8; -.
DR   SMR; Q9UBS8; -.
DR   BioGrid; 114968; 29.
DR   IntAct; Q9UBS8; 18.
DR   MINT; MINT-1187964; -.
DR   STRING; 9606.ENSP00000324956; -.
DR   iPTMnet; Q9UBS8; -.
DR   PhosphoSitePlus; Q9UBS8; -.
DR   BioMuta; RNF14; -.
DR   DMDM; 17380293; -.
DR   EPD; Q9UBS8; -.
DR   PaxDb; Q9UBS8; -.
DR   PeptideAtlas; Q9UBS8; -.
DR   PRIDE; Q9UBS8; -.
DR   DNASU; 9604; -.
DR   Ensembl; ENST00000347642; ENSP00000324956; ENSG00000013561. [Q9UBS8-1]
DR   Ensembl; ENST00000356143; ENSP00000348462; ENSG00000013561. [Q9UBS8-1]
DR   Ensembl; ENST00000394514; ENSP00000378022; ENSG00000013561. [Q9UBS8-2]
DR   Ensembl; ENST00000394519; ENSP00000378027; ENSG00000013561. [Q9UBS8-1]
DR   Ensembl; ENST00000394520; ENSP00000378028; ENSG00000013561. [Q9UBS8-1]
DR   GeneID; 9604; -.
DR   KEGG; hsa:9604; -.
DR   UCSC; uc003lly.4; human. [Q9UBS8-1]
DR   CTD; 9604; -.
DR   DisGeNET; 9604; -.
DR   GeneCards; RNF14; -.
DR   HGNC; HGNC:10058; RNF14.
DR   HPA; HPA008716; -.
DR   MIM; 605675; gene.
DR   neXtProt; NX_Q9UBS8; -.
DR   OpenTargets; ENSG00000013561; -.
DR   PharmGKB; PA34423; -.
DR   eggNOG; KOG1814; Eukaryota.
DR   eggNOG; ENOG410Y5R1; LUCA.
DR   GeneTree; ENSGT00840000129738; -.
DR   HOGENOM; HOG000237334; -.
DR   HOVERGEN; HBG057296; -.
DR   InParanoid; Q9UBS8; -.
DR   KO; K11971; -.
DR   OMA; FQIQIRD; -.
DR   OrthoDB; EOG091G08QR; -.
DR   PhylomeDB; Q9UBS8; -.
DR   TreeFam; TF314401; -.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; RNF14; human.
DR   GeneWiki; RNF14; -.
DR   GenomeRNAi; 9604; -.
DR   PRO; PR:Q9UBS8; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000013561; -.
DR   CleanEx; HS_RNF14; -.
DR   ExpressionAtlas; Q9UBS8; baseline and differential.
DR   Genevisible; Q9UBS8; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0000151; C:ubiquitin ligase complex; IBA:GO_Central.
DR   GO; GO:0050681; F:androgen receptor binding; IPI:UniProtKB.
DR   GO; GO:0003713; F:transcription coactivator activity; TAS:UniProtKB.
DR   GO; GO:0031624; F:ubiquitin conjugating enzyme binding; IBA:GO_Central.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IBA:GO_Central.
DR   GO; GO:0019787; F:ubiquitin-like protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0030521; P:androgen receptor signaling pathway; NAS:UniProtKB.
DR   GO; GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0000209; P:protein polyubiquitination; IBA:GO_Central.
DR   GO; GO:0016567; P:protein ubiquitination; IEP:UniProtKB.
DR   GO; GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   GO; GO:0060765; P:regulation of androgen receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; TAS:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   Gene3D; 3.10.110.10; -; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR031127; E3_UB_ligase_RBR.
DR   InterPro; IPR002867; IBR_dom.
DR   InterPro; IPR006575; RWD-domain.
DR   InterPro; IPR016135; UBQ-conjugating_enzyme/RWD.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   PANTHER; PTHR11685; PTHR11685; 1.
DR   Pfam; PF01485; IBR; 2.
DR   Pfam; PF05773; RWD; 1.
DR   SMART; SM00647; IBR; 2.
DR   SMART; SM00591; RWD; 1.
DR   SUPFAM; SSF54495; SSF54495; 1.
DR   PROSITE; PS50908; RWD; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Complete proteome; Cytoplasm;
KW   Metal-binding; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Transcription; Transcription regulation; Transferase; Ubl conjugation;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN         1    474       E3 ubiquitin-protein ligase RNF14.
FT                                /FTId=PRO_0000056057.
FT   DOMAIN       11    137       RWD. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00179}.
FT   ZN_FING     220    270       RING-type 1; atypical.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00175}.
FT   ZN_FING     289    350       IBR-type.
FT   ZN_FING     404    433       RING-type 2; degenerate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00175}.
FT   REGION      361    474       Interaction with androgen receptor.
FT   COILED      351    395       {ECO:0000255}.
FT   MOTIF        37     45       D-box.
FT   ACT_SITE    417    417       {ECO:0000250|UniProtKB:Q9Y4X5}.
FT   MOD_RES     348    348       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1    126       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045780.
FT   MUTAGEN     220    220       C->S: Loss of interaction with UBE2E2 and
FT                                of autoubiquitination.
FT                                {ECO:0000269|PubMed:11322894}.
FT   CONFLICT     32     32       Q -> R (in Ref. 4; CAG32983).
FT                                {ECO:0000305}.
SQ   SEQUENCE   474 AA;  53837 MW;  529E3F5AF38A5DAD CRC64;
     MSSEDREAQE DELLALASIY DGDEFRKAES VQGGETRIYL DLPQNFKIFV SGNSNECLQN
     SGFEYTICFL PPLVLNFELP PDYPSSSPPS FTLSGKWLSP TQLSALCKHL DNLWEEHRGS
     VVLFAWMQFL KEETLAYLNI VSPFELKIGS QKKVQRRTAQ ASPNTELDFG GAAGSDVDQE
     EIVDERAVQD VESLSNLIQE ILDFDQAQQI KCFNSKLFLC SICFCEKLGS ECMYFLECRH
     VYCKACLKDY FEIQIRDGQV QCLNCPEPKC PSVATPGQVK ELVEAELFAR YDRLLLQSSL
     DLMADVVYCP RPCCQLPVMQ EPGCTMGICS SCNFAFCTLC RLTYHGVSPC KVTAEKLMDL
     RNEYLQADEA NKRLLDQRYG KRVIQKALEE MESKEWLEKN SKSCPCCGTP IEKLDGCNKM
     TCTGCMQYFC WICMGSLSRA NPYKHFNDPG SPCFNRLFYA VDVDDDIWED EVED
//
